Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.

Blaha V, Musil F, Smahelova A, Ticha A, Hyspler R, Haluzik M, Lesna J, Sobotka L.

Neuro Endocrinol Lett. 2012;33 Suppl 2:6-12.

PMID:
23183502
2.

Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity.

Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B.

Diabetes Obes Metab. 2007 Sep;9(5):761-3. Epub 2007 Mar 13.

PMID:
17359244
3.

Effects of body weight reduction on plasma leptin and adiponectin/leptin ratio in obese patients with type 1 diabetes mellitus.

Musil F, Blaha V, Ticha A, Hyspler R, Haluzik M, Lesna J, Smahelova A, Sobotka L.

Physiol Res. 2015;64(2):221-8. Epub 2014 Oct 15.

4.

Adipocyte fatty acid-binding protein in obese children before and after weight loss.

Reinehr T, Stoffel-Wagner B, Roth CL.

Metabolism. 2007 Dec;56(12):1735-41.

PMID:
17998029
5.

Beneficial effects of metformin in normoglycemic morbidly obese adolescents.

Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.

Metabolism. 2001 Dec;50(12):1457-61.

PMID:
11735093
6.

Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss.

Hoenig M, Thomaseth K, Waldron M, Ferguson DC.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R227-34. Epub 2006 Aug 10. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1291.

7.

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS.

Clin Chem. 2006 Mar;52(3):405-13. Epub 2006 Jan 19.

8.
9.

Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.

de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R.

Ann Nutr Metab. 2006;50(4):354-60. Epub 2006 Jun 28.

PMID:
16809903
10.
11.

Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.

Poynten AM, Markovic TP, Maclean EL, Furler SM, Freund J, Chisholm DJ, Campbell LV.

Int J Obes Relat Metab Disord. 2003 Oct;27(10):1212-8.

PMID:
14513069
12.

Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.

Corripio R, Gónzalez-Clemente JM, Pérez-Sánchez J, Näf S, Gallart L, Nosàs R, Vendrell J, Caixàs A.

Eur J Endocrinol. 2010 Dec;163(6):887-93. doi: 10.1530/EJE-10-0408. Epub 2010 Sep 24.

13.

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

Kelley DE, Goodpaster B, Wing RR, Simoneau JA.

Am J Physiol. 1999 Dec;277(6 Pt 1):E1130-41.

PMID:
10600804
14.

Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.

Yun KE, Kim SM, Choi KM, Park HS.

Metabolism. 2009 Jun;58(6):798-802. doi: 10.1016/j.metabol.2009.01.017.

PMID:
19368945
15.

Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss.

Stejskal D, Karpisek M, Bronsky J.

J Clin Lab Anal. 2008;22(5):380-2. doi: 10.1002/jcla.20270.

PMID:
18803274
16.

Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome.

Krzystek-Korpacka M, Patryn E, Bednarz-Misa I, Mierzchala M, Hotowy K, Czapinska E, Kustrzeba-Wojcicka I, Gamian A, Noczynska A.

J Pediatr Endocrinol Metab. 2011;24(11-12):921-8.

PMID:
22308843
17.

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes.

Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S.

Diabetes Care. 2004 Jan;27(1):33-40.

PMID:
14693963
18.

The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ.

Diabetes Care. 1998 May;21(5):687-94.

PMID:
9589225
20.

Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.

Supplemental Content

Support Center